| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.09 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.09 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |